Parkman Healthcare Partners LLC - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 212 filers reported holding XENON PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
Parkman Healthcare Partners LLC ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$8,160,217
-15.4%
209,290
-6.5%
1.09%
-7.6%
Q1 2024$9,640,703
-29.0%
223,942
-24.0%
1.18%
-38.2%
Q4 2023$13,577,935
+83.5%
294,788
+36.1%
1.91%
+41.1%
Q3 2023$7,400,559
-11.7%
216,644
-0.5%
1.36%
-6.7%
Q2 2023$8,382,990
-15.5%
217,740
-21.5%
1.45%
-32.7%
Q1 2023$9,923,959
+6.9%
277,283
+17.7%
2.16%
-12.7%
Q4 2022$9,285,410
+15.5%
235,491
+5.8%
2.47%
+8.2%
Q3 2022$8,036,000
-10.3%
222,597
-24.4%
2.28%
-30.8%
Q2 2022$8,960,000
-3.6%
294,559
-3.2%
3.30%
+21.3%
Q1 2022$9,299,000
-17.4%
304,186
-15.6%
2.72%
+9.5%
Q4 2021$11,262,000
+136.8%
360,502
+15.8%
2.48%
+106.6%
Q3 2021$4,755,000
-36.3%
311,207
-22.4%
1.20%
-26.3%
Q2 2021$7,470,000
+11.5%
401,207
+7.2%
1.63%
+5.0%
Q1 2021$6,702,000
+20.5%
374,395
+3.5%
1.56%
+9.1%
Q4 2020$5,563,000
+8.1%
361,689
-22.2%
1.42%
+4.5%
Q3 2020$5,146,000
-30.5%
464,825
-21.3%
1.36%
-34.6%
Q2 2020$7,402,000
+10.6%
590,2670.0%2.08%
-32.8%
Q1 2020$6,694,000
-13.2%
590,267
+0.4%
3.10%
+39.4%
Q4 2019$7,709,000588,0592.22%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
BVF INC/IL 3,516,851$44,101,0002.72%
Parkman Healthcare Partners LLC 590,267$7,402,0002.08%
ACUTA CAPITAL PARTNERS, LLC 517,500$6,489,0001.88%
Soleus Capital Management, L.P. 250,897$3,146,0001.79%
DAFNA Capital Management LLC 346,535$4,346,0001.25%
KNOTT DAVID M 169,000$2,119,0001.16%
Ghost Tree Capital, LLC 325,000$4,076,0001.08%
Avoro Capital Advisors LLC 2,800,000$35,112,0000.69%
NEA Management Company, LLC 992,107$12,441,0000.50%
Orbimed Advisors 2,497,917$31,324,0000.44%
View complete list of XENON PHARMACEUTICALS INC shareholders